Outcome of Board Meeting

5th August, 2026 BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza, 1st Floor, P J Towers, Bandra Kurla Complex, Dalal Street, Mumbai - 400 001 Bandra (East), Mumbai – 400 051 Scrip Code: 500199 Scrip Code: IGPL Dear Sir, Sub: Outcome of Board Meeting With reference to the above, we wish to inform you that the Board of Directors at their meeting held today have approved the standalone and consolidated unaudited financial results of the Company for the quarter ended 30th June, 2026, a copy whereof along with the Limited Review Report from the Statutory Auditors of the Company as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith. The meeting commenced at 3:15 p.m. and concluded at 4:00 p.m. Kindly take the same on your record. Thanking you, Yours faithfully, For I G Petrochemicals Limited Sudhir R Singh Company Secretary Encl.: As Above I G PETROCHEMICALS LIMITED Regd . OFF. T-10, 3rd Floor, Jairam Complex, Mala, Neugi Nagar, Panaji, Goa -403 001 Corp. Off. 401-404, Raheja Centre, Free Press Journal Marg, 214, Nariman Point, Mumbai -400 021 Email:igpl@igpetro.com,http://www.igpetro.com, CIN • L51496GA1988PLC000915 Statement of Unaudited Standalone Financial Results for the Quarter Ended June 30, 2026 (Rs. in Lakhs) SR. Quarter Ended Year Ended 30-06-2026 31-03-2026 30-06-2025 31-03-2026 PARTICULARS Unaudited Audited (refer note Unaudited Audited no.4) INCOME a) Revenue from Operations 61,779.96 52,427.38 47,004.63 1, 92,497.90 b) Other Income 727.16 557.65 1,084.69 2,868.75 Total Income 62,507.12 52,985.03 48,089.32 1, 95,366.65 2 EXPENSES a) Cost of Materials Consumed 48,272.96 36,667.09 37,316.09 1,49,303.62 b) Changes in Inventories of Finished Goods & Work-in-Progress (6,514.26) 1,433.42 561.62 929.23 c) Employees Benefits Expense 3,036.32 2,522.10 2,379.06 9,660.66 d) Finance Cost 957.20 972.37 822.77 3,751.68 e) Depreciation and Amortisation Expense 1,550.64 1,525.58 1,563.30 6, 154.45 f) Other Expenses 5,712.47 4,916.35 6,527.73 22,430.62 Total Expenses 53,015.33 48,036.91 49,170.57 1, 92,230.26 3 Profit/(Loss) before tax (1) - (2) 9,491.79 4,948.12 (1,081.25) 3,136.39 4 Tax Expense Current Tax 2,258.33 203.12 203.12 Deferred Tax 136.44 1,027.60 (259.84) 617.58 5 Profit/(Loss) after tax (3) - (4) 7,097.02 3,717.40 (821.41) 2,315.69 6 A. Other Comprehensive income/(loss) not be reclassified to profit or loss (i) Re-measurement gain/ (loss) on defined benefit plans 23.47 41.14 (8.69) 93.89 (ii) Income tax effect on these items (5.91) (10.35) 2.19 (23.63) Other Comprehensive income/ (loss) for the period/year, net of tax 17.56 30.79 (6.50) 70.26 7 Total comprehensive income for the period / year (5) + (6) 7,114.58 3,748.19 (827.91) 2,385.95 8 Paid up Equity Share Capital 3,079.81 3,079.81 3,079.81 3,079.81 (Face value of Rs.10/-per share) 9 Other Equity 1,28, 970.46 10 Earning per share (of Rs. 10 each) basic and diluted in Rs. (not annualised except for the year ended 31-03-2026) 23.04 12.07 (2.67) 7.52 NOTES:- 1 The above unaudited standalone financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors at its meeting held on August 5, 2026. These results have been subject to limited review by the statutory auditors of the Company, who have issued an unqualified review report. 2 The Company is engaged in the manufacture and sale of organic chemicals and accordingly has only a single reportable Segment. 3 The standalone financial results have been prepared in accordance with recognition and measurement principles laid down in Indian Accounting Standards 34, Interim Financial Reporting ('Ind AS 34'), prescribed under section 133 of the Companies Act 2013 ('the Act') and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended). 4 The figures for the quarter ended March 31, 2026 are the balancing figures between audited figures in respect of the full financial year and the limited review published year to date figures up to the third quarter of the financial year ended March 31, 2026. 5 Previous periods figures have been regrouped / reclassified where necessary. EQR I G PETROCHEMICALS LIMITED c--;----'"" {:;/ ·, I u/ Mur-·..., \ p. .A ,'/ 1 Nikunj Dhanuka ()\. ..__ Cha1rman & Managing Director Place: Mumbai / ;~~::, DIN 00193499 Date: August 5, 2026 I G PETROCHEMICALS LIMITED Regd . OFF. T-10, 3rd Floor, Jairam Complex, Mala, Neugi Nagar, Panaji, Goa• 403 001 Corp. Off. 401-404, Raheja Centre, Free Press Journal Marg, 214, Nariman Point, Mumbai. 400 021 Email:igpl@igpetro.com,http://www.igpetro.com, CIN -L51496GA1988PLC000915 Statement of Unaudited Consolidated Financial Results for the Quarter Ended June 30, 2026 (Rs. in Lakhs) SR. Quarter Ended Year Ended 30-06-2026 31-03-2026 30-06-2025 31-03-2026 PARTICULARS Unaudited Audited (refer note Unaudited Audited no.4) 1 INCOME a) Revenue from Operations 61,779.96 52,427.38 47,004.63 1,92,497.90 b) Other Income 661.13 491.64 1,001.82 2,586.52 Total Income 62,441.09 52,919.02 48,006.45 1, 95,084.42 2 EXPENSES a) Cost of Materials Consumed 48,272.96 36,667.09 37,316.09 1,49,303.62 b) Changes in Inventories of Finished Goods 6: Work-in-Progress (6,514.26) 1,433.42 561.62 929.23 c) Employees Benefits Expense 3,036.32 2,522.10 2,379.06 9,660.66 d) Finance Cost 1,074.05 1,077.87 865.81 4,100.59 e) Depreciation and Amortisation Expense 1,766.33 2,037.47 1,625.62 6,905.96 f) Other Expenses 5,766.84 5,143.72 6,816.81 23,141.73 Total Expenses 53,402.24 48,881.67 49,565.01 1,94,041.79 3 Profit/(Loss) before tax (1) • (2) 9,038.85 4,037.35 {1,558.56) 1,042.63 4 Tax Expense Current Tax 2,258.33 203.12 203.12 Deferred Tax 136.44 1,027.60 (259.84) 617.58 5 Profit/(Loss) after tax (3) • (4) 6,644.08 2,806.63 (1,298.72) 221. 93 6 A. Other Comprehensive income/(loss) not be reclassified to profit or loss (i) Re-measurement gain/(loss) on defined benefit plans 23.47 41.14 (8.69) 93.89 (ii) Income tax effect on these items (5.91) (10.35) 2.19 (23.63) B. Other Comprehensive income/(loss) to be reclassified to profit or loss (i) Exchange differnces of translation of a foreign operation (68. 97) 648.79 1,035.12 2,196.10 (ii) Income tax effect on these items Other Comprehensive income/(loss) for the period/year, net of tax (51.41) 679.58 1,028.62 2,266.36 7 Total comprehensive income for the period/ year (5) + (6) 6,592.67 3,486.21 (270.10) 2,488.29 8 Paid up Equity Share Capital 3,079.81 3,079.81 3,079.81 3,079.81 (Face value of Rs.10/-per share) 9 Other Equity 1,30,209.00 10 Earning per share (of Rs. 10 each) basic and diluted in Rs. (not annualised except for the year ended 31-03-2026) 21.57 9.11 (4.22) 0.72 NOTES:- 1 The above unaudited consolidated financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors at its meeting held on August 5, 2026. These results have been subject to limited review by the statutory auditors of the Company, who have issued an unqualified review report. 2 The Company is engaged in the manufacture and sale of organic chemicals and accordingly has only a single reportable Segment. 3 The consolidated financial results have been prepared in accordance with recognition and measurement principles laid down in Indian Accounting Standards 34, Interim Financial Reporting ('Ind AS 34'), prescribed under section 133 of the Companies Act 2013 ('the Act') and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended). 4 The figures for the quarter ended March 31, 2026 are the balancing figures between audited figures in respec [Showing first 8,000 characters — download PDF for full document]